Work

Guidelines on the management of arterial hypertension and related comorbidities in Latin America

Year: 2017
Type: article
Abstract: ABI, ankle-brachial index; ABPM, \nambulatory blood pressure monitoring; ACCORD, Action \nto Control Cardiovascular Risk in Diabetes; ACE-I, \nangiotensin-converting-enzyme-inhibitors; ARB, AT1 \nblockers; BP, blood pressure; CARMELA, Cardiovascular \nRisk Factor Multiple Evaluation in Latin America; CARMEN, \nCommunity Actions for Multifactorial Reduction of Non- \nCommunicable Diseases; CCB, calcium channel blocker; \nCCM, Wagner’s Chronic Care Model; CDC, Chronic \nDisease Center; CTA, computed tomography angiography; \nCV, cardiovascular; DALY, disability-adjusted life year; DPP- \n4, dipeptidyl-peptidase-4; GLP-1, glucagon-like peptide 1; \nHBPM, home blood pressure monitoring; HOPE, Heart \nOutcomes Prevention Evaluation; HOT, Hypertension \nOptimal Treatment; HT, hypertension; LA, Latin America; \nLASH, Latin American Society of Hypertension; MRA, \nmagnetic resonance angiography; NCD, noncommunicable \ndisease; OSAS, obstructive apnea–hypopnea syndrome; \nPAD, peripheral artery disease; PAHO, Pan American \nHealth Organization; RAAS, renin–angiotensin–aldosterone \nsystem; RISS, Redes Integradas de Servicios de Salud; \nSGLUT2, sodium–glucose cotransporter-2; SPRINT, SBP \nIntervention Trial; UKPDS, United Kingdom Prospective \nDiabetes Study; VIDA, Veracruz Initiative for Diabetes \nAwareness
Author: Task Force of the Latin American Society of Hypertension
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W2782397703
FWCI: 7.43
Cites: 113
Cited by: 86
Related to: 10